BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31912904)

  • 1. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
    Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
    J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.
    Johari B; Rahmati M; Nasehi L; Mortazavi Y; Faghfoori MH; Rezaeejam H
    Cell Biol Int; 2020 Dec; 44(12):2499-2511. PubMed ID: 32841450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells.
    Johari B; Ebrahimi-Rad M; Maghsood F; Lotfinia M; Saltanatpouri Z; Teimoori-Toolabi L; Sharifzadeh Z; Karimipoor M; Kadivar M
    Anticancer Agents Med Chem; 2017; 17(13):1786-1795. PubMed ID: 28403778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
    Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
    Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous targeted inhibition of Sox2-Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells.
    Johari B; Zargan J
    Cell Biol Int; 2017 Dec; 41(12):1335-1344. PubMed ID: 28833847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
    Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
    Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Oct4-Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells.
    Bigdelou Z; Mortazavi Y; Saltanatpour Z; Asadi Z; Kadivar M; Johari B
    Mol Biol Rep; 2020 Mar; 47(3):1859-1869. PubMed ID: 32016633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X; Zhang J; Wang L; Wei H; Tian Z
    BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation.
    Zhu X; Li Q; Li S; Chen B; Zou H
    Int J Oncol; 2015 Jan; 46(1):215-22. PubMed ID: 25334080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT).
    Bigdelou Z; Johari B; Kadivar M; Rismani E; Asadi Z; Rahmati M; Saltanatpour Z
    J Cell Physiol; 2019 Dec; 234(12):22765-22774. PubMed ID: 31115051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.
    Zhang Q; Hossain DM; Duttagupta P; Moreira D; Zhao X; Won H; Buettner R; Nechaev S; Majka M; Zhang B; Cai Q; Swiderski P; Kuo YH; Forman S; Marcucci G; Kortylewski M
    Blood; 2016 Mar; 127(13):1687-700. PubMed ID: 26796361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting c-Myc with decoy oligodeoxynucleotide-loaded polycationic nanoparticles inhibits cell growth and induces apoptosis in cancer stem-like cells (NTERA-2).
    Ghorbani R; Gharbavi M; Keshavarz B; Madanchi H; Johari B
    Mol Biol Rep; 2024 May; 51(1):623. PubMed ID: 38710891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes.
    Zhang X; Zhang J; Wei H; Tian Z
    Oncol Rep; 2007 Jun; 17(6):1377-82. PubMed ID: 17487394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells.
    Zhang X; Liu P; Zhang B; Wang A; Yang M
    Cancer Genet Cytogenet; 2010 Feb; 197(1):46-53. PubMed ID: 20113836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4-Sox2 complex decoy oligodeoxynucleotides.
    Johari B; Rezaeejam H; Moradi M; Taghipour Z; Saltanatpour Z; Mortazavi Y; Nasehi L
    Mol Biol Rep; 2020 Sep; 47(9):6793-6805. PubMed ID: 32865703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inorganic kernel - Supported asymmetric hybrid vesicles for targeting delivery of STAT3-decoy oligonucleotides to overcome anti-HER2 therapeutic resistance of BT474R.
    Shi K; Fang Y; Gao S; Yang D; Bi H; Xue J; Lu A; Li Y; Ke L; Lin X; Jin X; Li M
    J Control Release; 2018 Jun; 279():53-68. PubMed ID: 29655990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
    Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
    J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
    Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
    FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.